Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127459611 | 12745961 | 1 | I | 20160905 | 20160912 | 20160915 | 20160915 | EXP | PE-GLAXOSMITHKLINE-PE2016GSK133950 | GLAXOSMITHKLINE | 73.73 | YR | F | Y | 0.00000 | 20160915 | CN | PE | PE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127459611 | 12745961 | 1 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 2 PUFF(S), 1D | Y | Y | 21254 | 2 | DF | QD | |||||
| 127459611 | 12745961 | 2 | C | MELOXICAM. | MELOXICAM | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127459611 | 12745961 | 1 | Asthma |
| 127459611 | 12745961 | 2 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127459611 | 12745961 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127459611 | 12745961 | Aphasia | Aphasia |
| 127459611 | 12745961 | Asthmatic crisis | Asthmatic crisis |
| 127459611 | 12745961 | Discomfort | Discomfort |
| 127459611 | 12745961 | Hypersensitivity | Hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127459611 | 12745961 | 1 | 20120116 | 0 |